Clinical Trials Logo

Clinical Trial Summary

Patients confirmed COVID-19 with gastrointestinal manifestations will be included. Characteristics and outcomes will be described for them.


Clinical Trial Description

Patients diagnosed as confirmed Covid-19 according to WHO and Egyptian Ministry of Health and Population (MOH) definitions will be included.The following will be done for all patients:

Demographic characters; age, sex, presence of co-morbidities such as hypretension, diabetes mellitus, obstructive lung diseases, ischemic heart diseases...etc, history of contact to covid-19 patients or recent travelling abroad.Clinical Characteristics: By recording of clinical manifestation such as fever, cough, shortness of breath, sore throat, change in taste or smell, nausea,vomiting and diarrhea will be done. Complications and the type of treatment received by the patients will also be described including mechanical ventilation.

Laboratory data will also be included : blood picture, liver enzymes, ESR,CRP, serum ferritin, D-dimer and troponin.

Follow up of the patients will be done until improvement, deaths or complications to determine disease outcomes. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04490772
Study type Observational
Source Assiut University
Contact
Status Not yet recruiting
Phase
Start date July 2020
Completion date September 2020

See also
  Status Clinical Trial Phase
Completed NCT00772447 - China Registration Study in Patients With Skin Infections Phase 3
Completed NCT00381303 - GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men. Phase 3
Completed NCT01520597 - National Study on Listeriosis and Listeria
Completed NCT01326013 - A Two-Arm, Multi-Centre Clinical Evaluation of the xTAG Gastrointestinal Pathogen Panel Phase 2
Completed NCT06006078 - Aersosolization During Upper Endoscopy N/A
Withdrawn NCT02412891 - Evaluation of "UroShield" Device Impact Upon Side Effects and Complications of Urinary Catheter Usage N/A